What Is Micro-Immunotherapy?
Micro-immunotherapy is a therapeutic approach developed and widely used in Europe for over 50 years, yet it remains largely unknown in the U.S. market. It uses low-dose immune signaling molecules to support immune regulation by restoring accurate cellular communication rather than stimulating or suppressing immune function.
In This Expert Interview
Daniela Lawler will introduce micro-immunotherapy through a cell-membrane and lipid biology framework, explaining how immune signals rely on membrane integrity, receptor function, and fatty-acid balance to be received and resolved.
Drawing on over six years of clinical use, she will share why micro-immunotherapy has become an integral part of her practice and how it integrates seamlessly with BodyBio’s lipid-based membrane support strategies, including phospholipids and fatty-acid optimization, to support precise and resilient immune communication.
In this interview, Daniela will help us to answer the following questions:
- What is micro-immunotherapy?
- How is lipid-based membrane support part of micro-immunotherapy?
- How similar is this approach to Sherry Rogers MD’s “get an oil change” approach?
- Is lipid-based membrane support part of a mito cocktail?
- Does lipid-based membrane support include phosphotidyl choline?
- Do you solely use BodyBio products for lipid-based membrane support? If so, why?
- Can micro-immunotherapy help those with autism and mitochondrial function?
- What other conditions can micro-immunotherapy help?
Sign up to join us in this live interview and ask Daniela your own questions!
About Daniela Lawler FNT BA DipCNM NANP BSEM
Daniela Lawler is a Functional Nutritional Therapist and founder of Foundations of Health. She graduated from the world-renowned College of Naturopathic Medicine (CNM) in London in 2017, later joining the faculty as a lecturer from 2019–2022. Since then, she has built thriving practices in both the UK and Miami, Florida, supporting children and adults with complex, chronic conditions—often when conventional medicine has offered little hope.
Daniela has continued to expand her education with a strong focus on cellular health, immune regulation, and mitochondrial function as the root drivers of modern disease. She trained extensively in Mitochondrial Therapy with Dr. Michael Kucera and Sheri Dixon, shadowing their work in London clinics since 2017. Daniela became the first practitioner to introduce Micro-Immunotherapy to the United States, bringing a therapy with more than 50 years of history in Europe to American families.
Alongside her work in MIT, Daniela has trained with Justine Stenger in cell membrane medicine, is mentored by Dr. Patricia Kane, a pioneer in lipid research and IV phosphatidylcholine therapy, and has studied Dr. Bruce Hoffman’s 7 Stages of Healing Program for complex chronic illness. Daniela also integrates Dr. Jack Kruse’s circadian biology principles, ensuring every client plan addresses light, sleep, and alignment with natural rhythms. You can learn more about her at her website: https://danielalawler.com/
Disclaimer
This expert interview is not a substitute for medical advice, treatment, diagnosis, or consultation with a medical professional. It is intended for general informational purposes only and should not be relied on to make determinations related to treatment of a medical condition. Documenting Hope has not verified and does not guaranty the accuracy of the information provided in this expert interview.
Still Looking for Answers?
Visit the Documenting Hope Practitioner Directory to find a practitioner near you.
Join us inside our online membership community for parents, Healing Together, where you’ll find even more healing resources, expert guidance, and a community to support you every step of your child’s healing journey.
Sources & References
Adam, G., et al. The influence of choline treatment on behavioral and neurochemical autistic-like phenotype in Mthfr-deficient mice. Transl Psychiatry. 2020 Sep 18;10(1):316.
Cantor, D.S., et al. A report on phosphatidylcholine therapy in a Down syndrome child. Psychological Reports. 1986, 58, 207-217.Â
Chung, S.Y., et al. Administration of phosphatidylcholine increases brain acetylcholine concentration and improves memory in mice with dementia. J Nutr. 1995 Jun;125(6):1484-9.
Fodale, V., et al. The cholinergic system in Down's syndrome. J Intellect Disabil. 2006 Sep;10(3):261-74.
Gabis, L.V., et al. Improvement of Language in Children with Autism with Combined Donepezil and Choline Treatment. J Mol Neurosci. 2019 Oct;69(2):224-234.
Hamlin, J.C., et al. Dietary intake and plasma levels of choline and betaine in children with autism spectrum disorders. Autism Res Treat. 2013;2013:578429.
Hung, M.C., et al. Learning behaviour and cerebral protein kinase C, antioxidant status, lipid composition in senescence-accelerated mouse: influence of a phosphatidylcholine-vitamin B12 diet. Br J Nutr. 2001 Aug;86(2):163-71.
Jadavji, N.M., et al. B-vitamin and choline supplementation increases neuroplasticity and recovery after stroke. Neurobiol Dis. 2017 Jul;103:89-100.
Langley, E.A., et al. High maternal choline consumption during pregnancy and nursing alleviates deficits in social interaction and improves anxiety-like behaviors in the BTBR T+Itpr3tf/J mouse model of autism. Behav Brain Res. 2015 Feb 1;278:210-20.
Lockrow, J., et al. Cholinergic degeneration and memory loss delayed by vitamin E in a Down syndrome mouse model. Exp Neurol. 2009 Apr;216(2):278-89.
Moon, J., et al. Perinatal choline supplementation improves cognitive functioning and emotion regulation in the Ts65Dn mouse model of Down syndrome. Behav Neurosci. 2010 Jun;124(3):346-61.
Resseguie, M.E., et al. Aberrant estrogen regulation of PEMT results in choline deficiency-associated liver dysfunction. J Biol Chem. 2011 Jan 14;286(2):1649-58.
Skripuletz, T., et al. The choline pathway as a strategy to promote central nervous system (CNS) remyelination. Neural Regen Res. 2015 Sep;10(9):1369-70.
Zeisel, S.H. Choline: Critical Role During Fetal Development and Dietary Requirements in Adults. Annu Rev Nutr. 2006;26:229-50.
